Home » Antigen Express Awarded Japanese Patent
Antigen Express Awarded Japanese Patent
Generex Biotechnology’s subsidiary Antigen Express has been awarded a Japanese patent strengthening its proprietary antigen presentation technology platform.
The patent covers methods for enhancing antigen-specific T helper cell stimulation using small synthetic peptides.
The most advanced vaccine protected by the patent is an immunotherapeutic in Phase II trials for breast cancer and a Phase I trial for prostate cancer.
Other vaccine peptides using the same technology are in a Phase I trial examining their ability to induce an immune response against the H5N1 avian influenza virus, Generex said.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May